Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Lancaster
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lancaster, CA

Studies commonly pay $75 to $4,500 per completed study

105 clinical trials are currently recruiting participants within 30 miles of Lancaster. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

105studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Lancaster right now

Top 25 of 105 recruiting studies, sorted by proximity — each links to its official registry page

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis Phase 3 Interventional 2,150 participants sought
Akero Clinical Study Site — Lancaster, California (2.2 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06528314)

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Healthy Phase 3 Interventional 6,000 participants sought
Antelope Valley Medical Center — Lancaster, California (2.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07160244)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought
First Valley Medical Group — Lancaster, California (2.2 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07064473)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (2.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07165028)

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 600 participants sought
Gastro Care Associates — Lancaster, California (2.2 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06819878)

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

Vitiligo, Non-Segmental Vitiligo (NSV) Phase 2 Interventional 66 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (29.5 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07533019)

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Metabolic Dysfunction-Associated SteatoHepatitis (MASH) Phase 2 Interventional 120 participants sought
Om Research Llc — Lancaster, California (2.2 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05519475)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061977)

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Colonic Polyps N/A Interventional 330 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi) · Sponsor: Capso Vision, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07089615)

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD) Phase 2 Interventional 195 participants sought
Amicis Research Center — Santa Clarita, California (29.5 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07271186)

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 425 participants sought
Om Research LLC — Lancaster, California (2.2 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06819891)

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease Phase 2, Phase 3 Interventional 1,092 participants sought
Om Research, LLC 1 — Lancaster, California (2.2 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196722)

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma Phase 2 Interventional 227 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05890352)

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Acne Phase 1, Phase 2 Interventional 800 participants sought
Chemidox Clinical Trials- Site Number : 8400075 — Lancaster, California (2.2 mi) · Sponsor: Sanofi Pasteur, a Sanofi Company
See eligibility & contact on ClinicalTrials.gov (NCT06316297)

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

Severe Asthma Phase 2 Interventional 512 participants sought
Research site — Lancaster, California (2.2 mi) · Sponsor: Kinaset Therapeutics Inc
See eligibility & contact on ClinicalTrials.gov (NCT07532265)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought
Clinical Trial Site — Lancaster, California (2.2 mi) · Sponsor: Alnylam Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07181109)

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06500455)

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Diabetes Mellitus, Type 2 Phase 2 Interventional 270 participants sought
First Valley Medical Group — Lancaster, California (2.2 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07415954)

A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Juvenile Psoriatic Arthritis Phase 3 Interventional 60 participants sought
Local Institution - 0038 — Lancaster, California (2.2 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT06869551)

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

Resectable Colorectal Carcinoma, Stage II Colorectal Cancer AJCC v8 N/A Interventional 150 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi) · Sponsor: City of Hope Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT07125729)

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Eosinophilic Asthma Phase 2 Interventional 264 participants sought
Kymera Investigative Site — Lancaster, California (2.2 mi) · Sponsor: Kymera Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07323654)

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis, Atopic Dermatitis Eczema Phase 2 Interventional 405 participants sought
Inmagene Site 1 — Lancaster, California (2.2 mi) · Sponsor: Inmagene LLC
See eligibility & contact on ClinicalTrials.gov (NCT07037901)
Actively enrolling

Studies you may be able to join near Lancaster

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Lancaster

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Om Research Clinical Trials

★ 3.0
1601 W Ave J Fl 2, Lancaster, CA 93534
(661) 388-2239

Research Center-Clinical

1314 W Ave J, Lancaster, CA 93534
(661) 726-1515

Antelope Valley Clinical Trials

44453 16th St W Ste 101, Lancaster, CA 93534
(661) 266-8944

Clinical Research Group of Los Angeles

43700 17th St W, Lancaster, CA 93534

Chemidox Clinical Trials Inc.

★ 4.0
44404 16th St W Ste 101, Lancaster, CA 93534
(833) 324-3643
"Steven and Ailene and Stefany were all very helpful and professional. My experience with Chemidox was an enjoyable one. The staff was knowledgeable a…"
— Shawna Bullock, 5★

City of Hope Antelope Valley

★ 3.6
City of Hope Antelope Valley, 44151 15th St W, Lancaster, CA 93534
(661) 524-9709
"Dr Weston Bush saved my husband by performing emergency surgery. He continued to monitor him for the following 5wks after, as my husband suffered fro…"
— Nicole Johnson, 5★

C&C Market Research

★ 4.7
1233 Rancho Vista Blvd #505, Palmdale, CA 93551
(661) 575-0777
"Great place. Great people. Top secret!"
— Melissa Morch, 5★

Long Beach Research Institute

★ 4.7
3300 E South St #205, Long Beach, CA 90805
(562) 471-3773
"Came here for a research study. Great place."
— Anthony Roberts, 5★

Flourish Research - Los Angeles (Northridge)

★ 4.9
18433 Roscoe Blvd #208, Northridge, CA 91325
(818) 280-4220
"This clinic is the best and stuff are great and caring if you need to get studied go here in Northridge ."
— John Cariaga (Jon jon), 5★

Clinical trials in Lancaster: what's recruiting

The Lancaster area currently has 105 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lancaster, the most active research areas are:

  • Diabetes & Metabolism6 studies
  • Cancer & Oncology6 studies
  • Liver & Kidney5 studies
  • Immune & Skin5 studies
  • Heart & Vascular2 studies

Every listing shows the study phase, the recruiting site and its distance from Lancaster, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lancaster

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lancaster participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Lancaster pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Lancaster?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Lancaster safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Lancaster?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Lancaster

Other metros within reach

Palmdale, CA129 Santa Clarita, CA2,384 Glendale, CA2,964 Los Angeles, CA2,949 Pomona, CA3,148 Rancho Cucamonga, CA1,489 Victorville, CA51 Fullerton, CA3,251

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Lancaster Bladder Issues Due To Spinal Cord Injury in Lancaster All conditions

More of CA

Long Beach3,366 Torrance3,258 Fullerton3,251 Anaheim3,193 Garden Grove3,186 Pomona3,148 Glendale2,964 Los Angeles2,949 Huntington Beach2,867 Santa Clarita2,384 Hayward2,257 Oakland2,248

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts